Q4 2024 Earnings Call Transcript March 18, 2025 MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

Vectors for Infection Risk in the United States Act (Mink VIRUS Act), bipartisan legislation endorsed by the Animal Welfare ...

MiNK Therapeutics (NASDAQ:INKT – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a report issued on Tuesday,Benzinga reports. They currently have a ...

We ended the year with a cash balance of $4.6 million. Cash used in operations for the three and twelve months ended December 31, 2024, was $1.7 million, and $9.6 million, respectively, compared to $3 ...

MiNK advanced its mission to bring off-the-shelf iNKT cell therapies to patients fighting hard-to-treat cancers and severe ...

SPRINGFIELD, Ill. (WAND) — A bill filed by a State House Democrat would add regulations on an unregulated minx fur trade in ...

For the first time in five years, since 2019, the Southwest Virginia Wildlife Center is caring for an American Mink. The mink ...

Patsy Takemoto Mink shattered barriers as the first Asian American woman in Congress and a champion of Title IX. Now, her ...

MiNK Therapeutics NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the ...

Hello, everyone, and welcome to MiNK Therapeutics fourth-quarter 2024 financial results call. Please note that this call is being recorded. (Operator Instructions) I'd now like to hand the call over ...